News

In response to the U.S. Food and Drug Administration's (FDA) recent recommendation to ban synthetic 7-Hydroxymitragynine (7-OH) products, Authentic Kratom, a leading U.S.-based online kratom retailer, ...
Germany’s Bayer and privately-held Kumquat Biosciences, a US biotech founded by pioneers of the KRAS pathway, have entered into an exclusive global license and collaboration to develop and ...
Bayer & Kumquat Biosciences enter global license and collaboration to develop and commercialize Kumquat’s KRAS G12D inhibitor: Berlin, Germany Wednesday, August 13, 2025, 11:00 ...
Researchers have developed edible microbeads made from green tea polyphenols, vitamin E and seaweed that, when consumed, bind ...
Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company founded by pioneers of the KRAS pathway, today announced that they have entered into an exclusive global license and collaboration ...
Conservatives, anti-abortion groups and members of the “Make America Healthy Again” movement have pushed for a method known as “restorative reproductive medicine” instead.
Former Teva North America CEO Sven Dethlefs, PhD, to lead Celea PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated ...
The Food and Drug Administration (FDA) is recommending banning a compound found in unregulated tablets, gummies and drink mixes sold online and at gas stations and convenience stores, the Trump ...
The anti-vaccine organization founded by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is now funding a lawsuit against him, arguing Kennedy has failed to establish a task force o… ...
The panel’s reinstatement is one of a series of controversial moves made by Robert F. Kennedy Jr. to put vaccines under new ...
The U.S. Food and Drug Administration has approved PTC Therapeutics' oral drug to treat a rare inherited metabolic disorder that prevents the body from properly breaking down certain amino acids ...
Large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive type of lung cancer, has a high chance of metastasis, no standard treatment and a poor survival rate. A study published in Nature ...